FDA approved first generic of drug used to treat severe hypoglycemia
On Dec. 28, 2020, the FDA approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia (very low blood sugar), which may occur in patients with diabetes mellitus.
The FDA granted approval of this generic glucagon for injection to Amphastar Pharmaceuticals of Rancho Cucamonga, Calif.
Tags:
Source: U.S. Food and Drug Administration
Credit:
